Table 2.
Subgroup study of antibiotics in bacteriuria.
| Antibiotic | Studies (n) | Patients (n) | Effect estimate RR (95% CI) |
|---|---|---|---|
| Ciprofloxacin | 3 | 506 | 0.38 (0.16, 0.87) |
| Levofloxacin | 3 | 318 | 0.42 (0.22, 0.79) |
| Norfloxacin | 1 | 262 | 0.70 (0.30, 1.64) |
| Cinoxacin | 1 | 31 | 0.16 (0.02, 1.55) |
| NF-PNPD | 2 | 198 | 0.38 (0.14, 1.05) |
| Trimethoprim | 1 | 82 | 0.37 (0.04, 3.71) |
| SMZ-TMP | 2 | 181 | 0.40 (0.10, 1.58) |
| FT | 1 | 270 | 0.97 (0.19, 4.89) |
| AMX-CA | 1 | 130 | 0.13 (0.02, 0.97) |
| Nitrofurantoin | 1 | 110 | 0.22 (0.03, 1.79) |
NF-PNPD: nitrofurantoin-phenazopyridine hydrochloride; SMZ-TMP: sulfamethoxazole-trimethoprim; FT: fosfomycin tromethamine; AMX-CA: amoxicillin-clavulanic acid.